Treatment of hepatocellular carcinoma associated with advanced cirrhosis by transcatheter arterial chemoembolization using autologous blood clot: A preliminary report
Toshiaki Gunji, Nobuo Kawauchi, Shin Ohnishi, Takashi Ishikawa, Hitoshi Nakagama, Takashi Kaneko, Takashi Moriyama, Nobuyuki Matsuhashi, Yoshio Yazaki, Michio Imawari – 1 February 1992 – Twenty‐two patients with hepatocellular carcinoma were treated by a new method of transcatheter arterial chemoembolization using an autologous blood clot as an embolizing agent. All had underlying advanced cirrhosis (14 Child's class B and 8 Child's class C patients). The median follow‐up interval was 11 mo (range = 2 to 30 mo).